HMGN5 and glioblastoma: CCK8 assays were used to investigate the effect of the interference of HMGN5 on glioblastoma cell proliferation, and the results indicated that the proliferation capacity was suppressed while being transfected with HMGN5-siRNA 48 hours (Figure 2(b)).